{"disease":{"id":"newly-diagnosed-peripheral-t-cell-lymphoma","name":"newly diagnosed peripheral t cell lymphoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03631862","title":"Treatment of Newly Diagnosed Peripheral T-cell Lymphoma","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Zhengzhou University","has_results":false},{"nct_id":"NCT05896813","title":"CMOP Regimen and Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}